Cholesterol treatment guidelines update

Richard Safeer, Prabha S. Ugalat

Research output: Contribution to journalArticle

Abstract

Hypercholesterolemia is one of the major contributors to atherosclerosis and coronary heart disease in our society. The National Cholesterol Education Program of the National Institutes of Health has created a set of guidelines that standardize the clinical assessment and management of hypercholesterolemia for practicing physicians and other professionals in the medical community. In May 2001, the National Cholesterol Education Program released its third set of guidelines, reflecting changes in cholesterol management since their previous report in 1993. In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia. The major risk factors that modify low-density lipoprotein goals include age, smoking status, hypertension, high-density lipoprotein levels, and family history. The concept of "CHD equivalent" is introduced - conditions requiring the same vigilance used in patients with coronary heart disease. Patients with diabetes and those with a 10-year cardiac event risk of 20 percent or greater are considered CHD equivalents. Once low-density lipoprotein cholesterol is at an accepted level, physicians are advised to address the metabolic syndrome and hypertriglyceridemia.

Original languageEnglish (US)
Pages (from-to)871-880
Number of pages10
JournalAmerican Family Physician
Volume65
Issue number5
StatePublished - Mar 1 2002
Externally publishedYes

Fingerprint

Hypercholesterolemia
Cholesterol
Guidelines
Coronary Disease
Physicians
Education
Hypertriglyceridemia
National Institutes of Health (U.S.)
HDL Lipoproteins
LDL Lipoproteins
LDL Cholesterol
Atherosclerosis
Therapeutics
Smoking
Hypertension

ASJC Scopus subject areas

  • Family Practice

Cite this

Cholesterol treatment guidelines update. / Safeer, Richard; Ugalat, Prabha S.

In: American Family Physician, Vol. 65, No. 5, 01.03.2002, p. 871-880.

Research output: Contribution to journalArticle

Safeer, R & Ugalat, PS 2002, 'Cholesterol treatment guidelines update', American Family Physician, vol. 65, no. 5, pp. 871-880.
Safeer, Richard ; Ugalat, Prabha S. / Cholesterol treatment guidelines update. In: American Family Physician. 2002 ; Vol. 65, No. 5. pp. 871-880.
@article{f7bc7171501c4d78b3c97597ddcf3021,
title = "Cholesterol treatment guidelines update",
abstract = "Hypercholesterolemia is one of the major contributors to atherosclerosis and coronary heart disease in our society. The National Cholesterol Education Program of the National Institutes of Health has created a set of guidelines that standardize the clinical assessment and management of hypercholesterolemia for practicing physicians and other professionals in the medical community. In May 2001, the National Cholesterol Education Program released its third set of guidelines, reflecting changes in cholesterol management since their previous report in 1993. In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia. The major risk factors that modify low-density lipoprotein goals include age, smoking status, hypertension, high-density lipoprotein levels, and family history. The concept of {"}CHD equivalent{"} is introduced - conditions requiring the same vigilance used in patients with coronary heart disease. Patients with diabetes and those with a 10-year cardiac event risk of 20 percent or greater are considered CHD equivalents. Once low-density lipoprotein cholesterol is at an accepted level, physicians are advised to address the metabolic syndrome and hypertriglyceridemia.",
author = "Richard Safeer and Ugalat, {Prabha S.}",
year = "2002",
month = "3",
day = "1",
language = "English (US)",
volume = "65",
pages = "871--880",
journal = "American Family Physician",
issn = "0002-838X",
publisher = "American Academy of Family Physicians",
number = "5",

}

TY - JOUR

T1 - Cholesterol treatment guidelines update

AU - Safeer, Richard

AU - Ugalat, Prabha S.

PY - 2002/3/1

Y1 - 2002/3/1

N2 - Hypercholesterolemia is one of the major contributors to atherosclerosis and coronary heart disease in our society. The National Cholesterol Education Program of the National Institutes of Health has created a set of guidelines that standardize the clinical assessment and management of hypercholesterolemia for practicing physicians and other professionals in the medical community. In May 2001, the National Cholesterol Education Program released its third set of guidelines, reflecting changes in cholesterol management since their previous report in 1993. In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia. The major risk factors that modify low-density lipoprotein goals include age, smoking status, hypertension, high-density lipoprotein levels, and family history. The concept of "CHD equivalent" is introduced - conditions requiring the same vigilance used in patients with coronary heart disease. Patients with diabetes and those with a 10-year cardiac event risk of 20 percent or greater are considered CHD equivalents. Once low-density lipoprotein cholesterol is at an accepted level, physicians are advised to address the metabolic syndrome and hypertriglyceridemia.

AB - Hypercholesterolemia is one of the major contributors to atherosclerosis and coronary heart disease in our society. The National Cholesterol Education Program of the National Institutes of Health has created a set of guidelines that standardize the clinical assessment and management of hypercholesterolemia for practicing physicians and other professionals in the medical community. In May 2001, the National Cholesterol Education Program released its third set of guidelines, reflecting changes in cholesterol management since their previous report in 1993. In addition to modifying current strategies of risk assessment, the new guidelines stress the importance of an aggressive therapeutic approach in the management of hypercholesterolemia. The major risk factors that modify low-density lipoprotein goals include age, smoking status, hypertension, high-density lipoprotein levels, and family history. The concept of "CHD equivalent" is introduced - conditions requiring the same vigilance used in patients with coronary heart disease. Patients with diabetes and those with a 10-year cardiac event risk of 20 percent or greater are considered CHD equivalents. Once low-density lipoprotein cholesterol is at an accepted level, physicians are advised to address the metabolic syndrome and hypertriglyceridemia.

UR - http://www.scopus.com/inward/record.url?scp=0036500807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036500807&partnerID=8YFLogxK

M3 - Article

C2 - 11898959

AN - SCOPUS:0036500807

VL - 65

SP - 871

EP - 880

JO - American Family Physician

JF - American Family Physician

SN - 0002-838X

IS - 5

ER -